- Home
- ENSC vs CSCI Comparison
ENSC vs CSCI Comparison
Compare ENSC & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- CSCI
- Stock Information
- Founded
- ENSC 2003
- CSCI 1990
- Country
- ENSC United States
- CSCI Canada
- Employees
- ENSC N/A
- CSCI N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- ENSC Health Care
- CSCI
- Exchange
- ENSC Nasdaq
- CSCI NYSE
- Market Cap
- ENSC 9.8M
- CSCI 11.1M
- IPO Year
- ENSC N/A
- CSCI 1996
- Fundamental
- Price
- ENSC $7.77
- CSCI $3.00
- Analyst Decision
- ENSC
- CSCI
- Analyst Count
- ENSC 0
- CSCI 0
- Target Price
- ENSC N/A
- CSCI N/A
- AVG Volume (30 Days)
- ENSC 100.5K
- CSCI 9.5K
- Earning Date
- ENSC 03-14-2025
- CSCI 11-12-2024
- Dividend Yield
- ENSC N/A
- CSCI N/A
- EPS Growth
- ENSC N/A
- CSCI N/A
- EPS
- ENSC N/A
- CSCI N/A
- Revenue
- ENSC $4,421,404.00
- CSCI $4,834,000.00
- Revenue This Year
- ENSC $89.78
- CSCI N/A
- Revenue Next Year
- ENSC N/A
- CSCI N/A
- P/E Ratio
- ENSC N/A
- CSCI N/A
- Revenue Growth
- ENSC 40.41
- CSCI N/A
- 52 Week Low
- ENSC $2.12
- CSCI $2.50
- 52 Week High
- ENSC $30.90
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- ENSC 50.09
- CSCI N/A
- Support Level
- ENSC $6.75
- CSCI N/A
- Resistance Level
- ENSC $9.57
- CSCI N/A
- Average True Range (ATR)
- ENSC 0.73
- CSCI 0.00
- MACD
- ENSC -0.13
- CSCI 0.00
- Stochastic Oscillator
- ENSC 36.17
- CSCI 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.